Douglas K. Hutchinson

Author

W.E. Upjohn Institute for Employment Research

Also Known As

D K Hutchinson, D. K. HUTCHINSON, Douglas Hutchinson, Douglas K Hutchinson, Douglas K. Hutchinson, Hutchinson, Douglas K.

Publications

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research Abbott Fund Abbott (United States)

About

Douglas K. Hutchinson is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	946
2	Biochemistry	5	5	144
3	Natural Sciences	4	4	127
4	Health Sciences	3	3	205
5	Engineering	1	1	38

Douglas K. Hutchinson

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Substituent Effects on the Antibacterial Activity of Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Expanded Activity Against the Fastidious Gram-Negative Organisms <i>Haemophilus </i><i>i</i><i>nfluenzae</i> and <i>Moraxella </i><i>c</i><i>atarrhalis</i> Michaël Génin, Debra A. Allwine, David Anderson, Journal of Medicinal Chemistry	2000	722
Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections Steven J. Brickner, Douglas K. Hutchinson, Michael R. Barbachyn, Journal of Medicinal Chemistry Antibacterial ActivityAntimicrobial ChemotherapyDrug ResistanceMycobacterium TuberculosisAntimicrobial Therapy	1996	570
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents Gary E. Zurenko, Betty H. Yagi, Ronda D. Schaadt, Antimicrobial Agents and Chemotherapy	1996	461
Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial Activity Michael R. Barbachyn, Douglas K. Hutchinson, Steven J. Brickner, Journal of Medicinal Chemistry	1996	234
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections Charles W. Ford, Judith C. Hamel, Daniel M. Wilson, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyNovel OxazolidinoneDrug ResistanceVivo ActivitiesExperimental Bacterial Infections	1996	138
Piperazinyl Oxazolidinone Antibacterial Agents Containing a Pyridine, Diazene, or Triazene Heteroaromatic Ring John A. Tucker, Debra A. Allwine, Kevin C. Grega, Journal of Medicinal Chemistry	1998	91
Highlights of the Structure–Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530) Rolf Wagner, John T. Randolph, Sachin Patel, Journal of Medicinal Chemistry	2018	53
U-87947E, a protein quinolone antibacterial agent incorporating a bicyclo[1.1.1]pent-1-yl (BCP) subunit Michael R. Barbachyn, Douglas K. Hutchinson, Dana S. Toops, Bioorganic & Medicinal Chemistry Letters AntibioticsMedicineAntibacterial AgentAntimicrobial ChemotherapyMicrobiology	1993	45
Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid Gary E. Zurenko, Charles W. Ford, Douglas K. Hutchinson, Expert Opinion on Investigational Drugs Oral BioavailabilityAntiparasitic AgentPharmacotherapyAntimicrobial ChemotherapyDrug Resistance	1997	44
Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors John T. Randolph, Charles A. Flentge, Peggy Huang, Journal of Medicinal Chemistry PharmacotherapyAntiviral DrugPharmaceutical ChemistryHcv PolymeraseMedicinal Chemistry	2009	39

Page 1